International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-4 doi: 10.5281/zenodo.13368949
Original Research Article
Correlation of C-Reactive Protein and Blood Culture in Diagnosis of Neonatal Sepsis
Published
Aug. 24, 2024
Abstract

Introduction: Neonatal sepsis is a clinical syndrome of systemic illness accompanied by bacteraemia in thefirst 28 days of life (neonates). Early onset sepsis is the culture positive infection within the first 72hours of life while late onset sepsis is the culture positive infection after 72 hours of life.Materials and Methods: 166 neonates, of which 83 suspected of early neonatal sepsis and 83 suspected of late onsetsepsis were included in the study over a period of two months. Blood culture andqualitative assessment of CRP was done for all the subjects.Results: Out of the 166 Neonates, 2(1.2%) were both Blood culture positive and CRP positive; 21(12.8%) were only Blood culture positive, CRP negative; 19(11.5%) were only CRP positive, Blood culture negative. Among 83 early onset sepsis cases, both CRP and blood culture was positive in 2(2.4%) cases. Blood culture alone was positive in 9(10.8%) cases and only CRP was positive in 19(22.8%) cases. Among 83 late onset sepsis cases, only Blood culture positive were seen in 14(16.8%) cases and only CRP was positive in 2(2.4%) cases. Conclusion: CRP plays a major role as acute phase reactant in diagnosis of early onset sepsis. But in lateonset sepsis, Blood culture plays a major role. So Blood culture is the gold standard fordiagnosis of neonatal sepsis.

Recommended Articles
Loading Image...
Volume-5, Issue-4
Citations
2330 Views
392 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved